A Novel De Novo Frameshift Mutation in KAT6A Identified by Whole Exome Sequencing

Abstract

Intellectual disability is a common condition with multiple etiologies. The number of monogenic causes has increased steadily in recent years due to the implementation of next generation sequencing. Here, we describe a 2-year-old boy with global developmental delay and intellectual disability. The child had feeding difficulties since birth. He had delayed motor skills and muscular hypotonia. Brain magnetic resonance imaging revealed diffuse white matter loss and thinning of the corpus callosum. Banded karyotype and comparative genomic hybridization (CGH) array were normal. Whole exome sequencing revealed a novel de novo frameshift mutation c.3390delA (p.Lys1130Asnfs*4) in KAT6A gene (NM_006766.4). The heterozygous mutation was confirmed by Sanger sequencing in the patient and its absence in his parents. KAT6A that encodes a histone acetyltransferase has been recently found to be associated with a neurodevelopmental disorder autosomal dominant mental retardation 32 (OMIM: no. 616268). Features of this disorder are nonspecific, which makes it difficult to characterize the condition based on the clinical symptoms alone. Therefore, our findings confirm the utility of whole exome sequencing to quickly and reliably identify the etiology of such conditions.

Keywords

developmental delay - intellectual disability - exome - KAT6A

• References

• 1 Ewans LJ, Schofield D, Shrestha R. , et al. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders. Genet Med 2018 doi: 10.1038/gim.2018.39
• 2 Vrijenhoek T, Middelburg EM, Monroe GR. , et al. Whole-exome sequencing in intellectual disability; cost before and after a diagnosis. Eur J Hum Genet 2018; 26 (11) 1566-1571
• 3 Arboleda VA, Lee H, Dorrani N. , et al; UCLA Clinical Genomics Center. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. Am J Hum Genet 2015; 96 (03) 498-506
• 4 Tham E, Lindstrand A, Santani A. , et al. Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features. Am J Hum Genet 2015; 96 (03) 507-513
• 5 Trujillano D, Oprea GE, Schmitz Y, Bertoli-Avella AM, Abou Jamra R, Rolfs A. A comprehensive global genotype-phenotype database for rare diseases. Mol Genet Genomic Med 2016; 5 (01) 66-75
• 6 Landrum MJ, Lee JM, Benson M. , et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 2016; 44 (D1): D862-D868
• 7 Stenson PD, Ball EV, Mort M. , et al. The Human Gene Mutation Database (HGMD) and its exploitation in the fields of personalized genomics and molecular evolution. Curr Protoc Bioinformatics 2012. ; Chap. 1: Unit 1.13. doi: 10.1002/0471250953.bi0113s39
• 8 Lek M, Karczewski KJ, Minikel EV. , et al; Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016; 536 (7616): 285-291
• 9 Baell JB, Leaver DJ, Hermans SJ. , et al. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth. Nature 2018; 560 (7717): 253-257
• 10 Sheikh BN, Metcalf D, Voss AK, Thomas T. MOZ and BMI1 act synergistically to maintain hematopoietic stem cells. Exp Hematol 2017; 47: 83-97.e8
• 11 You L, Zou J, Zhao H. , et al. Deficiency of the chromatin regulator BRPF1 causes abnormal brain development. J Biol Chem 2015; 290 (11) 7114-7129
• 12 Voss AK, Vanyai HK, Collin C. , et al. MOZ regulates the Tbx1 locus, and Moz mutation partially phenocopies DiGeorge syndrome. Dev Cell 2012; 23 (03) 652-663
• 13 Eising E, Carrion-Castillo A, Vino A. , et al. A set of regulatory genes co-expressed in embryonic human brain is implicated in disrupted speech development. Mol Psychiatry 2018 doi: 10.1038/s41380-018-0020-x
• 14 Trinh J, Hüning I, Yüksel Z. , et al. A KAT6A variant in a family with autosomal dominantly inherited microcephaly and developmental delay. J Hum Genet 2018; 63 (09) 997-1001
• 15 Zwaveling-Soonawala N, Maas SM, Alders M. , et al. Variants in KAT6A and pituitary anomalies. Am J Med Genet A 2017; 173 (09) 2562-2565
• 16 Millan F, Cho MT, Retterer K. , et al. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder. Am J Med Genet A 2016; 170 (07) 1791-1798
• 17 Satoh C, Maekawa R, Kinoshita A. , et al. Three brothers with a nonsense mutation in KAT6A caused by parental germline mosaicism. Hum Genome Var 2017; 4: 17045
• 18 Efthymiou S, Salpietro V, Bettencourt C, Houlden H. Paroxysmal movement disorder and epilepsy caused by a de novo truncating mutation in KAT6A . J Pediatr Genet 2018; 7 (03) 114-116
• 19 Elenius V, Lähdesmäki T, Hietala M, Jartti T. Food allergy in a child with de novo KAT6A mutation. Clin Transl Allergy 2017; 7: 19
• 20 Murray CR, Abel SN, McClure MB. , et al. Novel causative variants in DYRK1A, KARS, and KAT6A associated with intellectual disability and additional phenotypic features. J Pediatr Genet 2017; 6 (02) 77-83
• 21 Gauthier-Vasserot A, Thauvin-Robinet C, Bruel AL. , et al. Application of whole-exome sequencing to unravel the molecular basis of undiagnosed syndromic congenital neutropenia with intellectual disability. Am J Med Genet A 2017; 173 (01) 62-71